BioCentury
ARTICLE | Financial News

Repros raises $71.3 million in follow-on

June 21, 2013 12:48 AM UTC

Repros Therapeutics Inc. (NASDAQ:RPRX) raised $71.3 million through the sale of 3.8 million shares at $19 in a follow-on underwritten by BofA Merrill Lynch; Lazard; Ladenburg Thalmann; and Ascendiant....